Name | EMT inhibitor-1 |
---|
Description | EMT inhibitor-1 is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities. |
---|---|
Related Catalog | |
Target |
Hippo, TGF-β, Wnt[1]. |
In Vitro | EMT inhibitor-1 (C19) is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities, inhibiting cancer cell migration, proliferation, and resistance to doxorubicin in vitro[1]. |
In Vivo | EMT inhibitor-1 (C19) exerts strong antitumor activity in a mouse tumor model. Mechanistically, EMT inhibitor-1 induces GSK3-β–mediated degradation of the Hippo transducer TAZ, through activation of the Hippo kinases Mst/Lats and the tumor suppressor kinase AMPK upstream of the degradation complex[1]. |
References |
Molecular Formula | C12H12Cl2N2O2S |
---|---|
Molecular Weight | 319.21 |
Storage condition | 2-8℃ |